Share This Author
Endometrial cancer.
- F. Amant, P. Moerman, P. Neven, D. Timmerman, E. van Limbergen, I. Vergote
- MedicineThe Lancet
- 2005
Current concepts about epidemiology, pathology, pathogenesis, risk factors and prevention, diagnosis, staging, prognostic factors, treatment, and follow-up of endometrial cancer are reviewed.
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
- I. Vergote, C. Tropé, N. Reed
- MedicineNew England Journal of Medicine
- 2 September 2010
Neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary debulked surgery followed by chemotherapy as a treatment option for patients with bulky stage IIIC or IV ovarian carcinoma in this study.
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
- N. Colombo, C. Creutzberg, C. Sessa
- MedicineAnnals of Oncology
- 2 December 2015
Results of this consensus conference on endometrial cancer, together with a summary of evidence supporting each recommendation, are detailed in this article.
Patient-derived xenograft models: an emerging platform for translational cancer research.
- M. Hidalgo, F. Amant, A. Villanueva
- BiologyCancer Discovery
- 9 January 2014
The current state of the art in this field is summarized, including methodologic issues, available collections, practical applications, challenges and shortcomings, and future directions, and a European consortium of PDX models is introduced.
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
- N. Colombo, C. Creutzberg, C. Sessa
- MedicineInternational Journal of Gynecologic Cancer
- 12 November 2015
Results of this consensus conference on endometrial cancer, together with a summary of evidence supporting each recommendation, are detailed in this article.
Endometrial cancer
- F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Limbergen, I. Vergote
- MedicineThe Lancet
- 12 August 2005
Clinical management of uterine sarcomas.
- F. Amant, A. Coosemans, M. Debiec‐Rychter, D. Timmerman, I. Vergote
- MedicineThe Lancet Oncology
- 1 December 2009
Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
- S. Deprez, F. Amant, S. Sunaert
- Medicine, PsychologyJournal of Clinical Oncology
- 20 January 2012
Evidence of longitudinal changes in cognitive functioning and cerebral WM integrity after chemotherapy as well as an association between both are reported.
Treatment of breast cancer during pregnancy: an observational study.
- S. Loibl, Sileny N. Han, F. Amant
- MedicineThe Lancet Oncology
- 16 August 2012
Melanoma addiction to the long non-coding RNA SAMMSON
- E. Leucci, R. Vendramin, J. Marine
- BiologyNature
- 24 March 2016
The results indicate that silencing of the lineage addiction oncogene SAMMSON disrupts vital mitochondrial functions in a cancer-cell-specific manner and is expected to deliver highly effective and tissue-restricted anti-melanoma therapeutic responses.
...
...